CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −2,323 | $4.26 | $10K | 179,186 |
| 2026-06-02 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −349 | $4.46 | $2K | 181,509 |
| 2026-05-29 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −303 | $5.01 | $2K | 181,858 |
| 2026-05-28 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −2,989 | $4.93 | $15K | 182,161 |
| 2026-05-22 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,165 | $5.69 | $7K | 194,924 |
| 2026-05-12 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −3,298 | $5.28 | $17K | 185,150 |
| 2026-05-11 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −6,476 | $5.76 | $37K | 188,448 |
| 2025-12-29 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −9,933 | $6.97 | $69K | 0 |
| 2025-12-02 | Golden Lee Scott Director | Grant or award · Stock Options | +5,000 | 5,000 | ||
| 2025-10-27 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,800 | $13.99 | $25K | 9,933 |
| 2025-10-27 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,315 | $13.99 | $18K | 196,089 |
| 2025-10-24 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,800 | $13.99 | $25K | 11,733 |
| 2025-10-24 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,129 | $14.03 | $16K | 197,404 |
| 2025-10-13 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,800 | $14.15 | $25K | 198,533 |
| 2025-10-13 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,800 | $14.07 | $25K | 13,533 |
| 2025-10-09 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,800 | $14.02 | $25K | 200,333 |
| 2025-10-09 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,693 | $13.99 | $24K | 15,333 |
| 2025-10-06 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −107 | $13.99 | $1K | 17,026 |
| 2025-10-02 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −500 | $14.13 | $7K | 202,133 |
| 2025-10-01 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,700 | $13.99 | $24K | 17,133 |
Page 2 of 5 · 88 trades